ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
PUBLIC · ALXONov 14, 2024
Company
ALX Oncology
San FranciscoBiotechnologyHealth CareMedicalTherapeutics
Description
ALX Oncology announced the appointment of Alan Sandler, M.D., as Chief Medical Officer. Dr. Sandler's extensive experience in oncology and drug development, including his in-depth knowledge of ALX Oncology, makes him the ideal leader to advance the clinical development of evorpacept, the company's investigational lead compound, into late-stage clinical trials.
Who to call at ALX Oncology, and when
A new leader at ALX Oncology brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day ALX Oncology raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ALX Oncology, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ALX Oncology
Location
San Francisco, California, United States
About
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ALX Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San FranciscoBiotechnologyHealth CareMedicalTherapeutics